Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 36.73% vs 4.15% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 13.49% vs 16.22% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 55.93% vs 40.67% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 29.94% vs 21.74% in Mar 2025
Compare Profit and Loss Results of Medico Remedies
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
206.00
95.00
111.00
116.84%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
206.00
95.00
111.00
116.84%
Expenditure (Ex Depriciation)
Stock Adjustments
-1.00
0.00
-1.00
0%
Raw Materials Consumed
153.00
70.00
83.00
118.57%
Power & Fuel Cost
3.00
1.00
2.00
200.00%
Employee Cost
7.00
7.00
0.00
0.00%
Operating Expenses
11.00
0.00
11.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
8.00
0.00
8.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
1.00
0.00
1.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
189.00
82.00
107.00
130.49%
Operating Profit (PBDIT) excl Other Income
17.00
13.00
4.00
30.77%
Other Income
5.00
2.00
3.00
150.00%
Operating Profit (PBDIT)
22.00
16.00
6.00
37.50%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
21.00
16.00
5.00
31.25%
Depreciation
3.00
0.00
3.00
0%
Profit Before Taxation & Exceptional Items
18.00
15.00
3.00
20.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
18.00
15.00
3.00
20.00%
Provision for Tax
4.00
4.00
0.00
0.00%
Profit After Tax
13.00
10.00
3.00
30.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
42.00
45.00
-3.00
-6.67%
Profit Available for appropriations
55.00
56.00
-1.00
-1.79%
Appropriations
55.00
56.00
-1.00
-1.79%
Equity Dividend (%)
0%
50%
-50.00
Earnings Per Share
1.58
18.78
-17.20
-91.59%
Profit And Loss - Net Sales
Net Sales 206.38 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 36.73% vs 4.15% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.03 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 13.49% vs 16.22% in Mar 2025
Profit And Loss - Interest
Interest 1.81 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 55.93% vs 40.67% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 13.12 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 29.94% vs 21.74% in Mar 2025
Footer loading
